Synergistic effects of a copper-cobalt-nitroisophthalic acid/neodymium oxide composite on the electrochemical performance of hybrid supercapacitors.

Hybrid supercapacitors can produce extraordinary advances in specific power and energy to display better electrochemical performance and better cyclic stability. Amalgamating metal oxides with metal-organic frameworks endows the prepared composites with unique properties and advantageous possibilities for enhancing the electrochemical capabilities. The present study focused on the synergistic effects of the CuCo(5-NIPA)-Nd2O3 composite. Employing a half-cell configuration, we conducted a comprehensive electrochemical analysis of CuCo(5-NIPA), Nd2O3, and their composite. Owing to the best performance of the composite, the hybrid device prepared from CuCo(5-NIPA)-Nd2O3 and activated carbon demonstrated a specific capacity of 467.5 C g-1 at a scan rate of 3 mV s-1, as well as a phenomenal energy and power density of 109.68 W h kg-1 and 4507 W kg-1, respectively. Afterwards, semi-empirical techniques and models were used to investigate the capacitive and diffusive mechanisms, providing important insights into the unique properties of battery-supercapacitor hybrids. These findings highlight the enhanced performance of the CuCo(5-NIPA)-Nd2O3 composite, establishing it as a unique and intriguing candidate for applications requiring the merging of battery and supercapacitor technologies.

Impact of Hyperuricemia and Urate-Lowering Agents on Cardiovascular Diseases.

The association between hyperuricemia and cardiovascular diseases has been studied for many years. Research has shown a link between high uric acid levels and increased risk of including coronary artery disease hypertension and other cardiovascular conditions. Urate-lowering therapy, particularly with xanthine oxidase inhibitors like allopurinol, has shown promising results in reducing blood pressure in individuals with hyperuricemia and hypertension. Clinical trials and studies have demonstrated significant reductions in both systolic and diastolic blood pressure with urate-lowering treatment. Urate-lowering treatment has shown a favorable effect on reducing systolic blood pressure and major adverse cardiovascular events in patients with previous cardiovascular disease. In terms of cardiovascular safety, clinical trials have indicated that xanthine oxidase inhibitors such as febuxostat are non-inferior to allopurinol and do not increase the risk of death or serious adverse events. Overall, these findings highlight the importance of managing hyperuricemia and utilizing urate-lowering therapy to mitigate the adverse cardiovascular effects associated with elevated uric acid levels.

Elucidating the redox activity of cobalt-1,2,3,4-cyclopentane-tetracarboxylic acid and 1,2,4,5-benzene-tetracarboxylic acid-based metal-organic frameworks for a hybrid supercapacitor.

The development of electrode materials with extraordinary energy densities or high power densities has experienced a spectacular upsurge because of significant advances in energy storage technology. In recent years, the family of metal-organic frameworks (MOFs) has become an essential contender for electrode materials. Herein, two cobalt-based MOFs are synthesized with distinct linkers named 1,2,4,5-benzene-tetra-carboxylic acid (BTCA) and 1,2,3,4-cyclopentane-tetracarboxylic acid (CPTC). Investigations have been rigorously conducted to fully understand the effect of linkers on the electrochemical properties of Co-based MOFs. The best sample among the MOFs was used with activated carbon to create a battery-supercapacitor hybrid device. Due to its noteworthy results, specific capacity (100.3 C g-1), energy density (23 W h kg-1), power density (3400 W kg-1) and with the lowest ESR value of 0.4 Ω as well as its 95.4% capacity retention, the fabricated hybrid device was discovered to be very appealing for applications demanding energy storage. An approach for evaluating battery-supercapacitors was employed by quantifying the capacitive and diffusive contributions using Dunn's model to reflect the bulk and surface processes occurring during charge storage. This study fills the gap between supercapacitors and batteries, as well as providing a roadmap for creating a new generation of energy storage technologies with improved features.

Pyridine 3,5-dicarboxylate-based metal-organic frameworks as an active electrode material for battery-supercapacitor hybrid energy storage devices.

Efficient energy storage and conversion is crucial for a sustainable society. Battery-supercapacitor hybrid energy storage devices offer a promising solution, bridging the gap between traditional batteries and supercapacitors. In this regard, metal-organic frameworks (MOFs) have emerged as the most versatile functional compounds owing to their captivating structural features, unique properties, and extensive diversity of applications in energy storage. MOF properties are governed by the structure and topological characteristics, which are influenced by the types of ligands and metal nodes. Herein, MOFs based on pyridine 3,5-dicarboxylate (PYDC) ligand in combination with copper and cobalt are electrochemically analyzed. Owing to the promising initial characterization of Cu-PYDC-MOF, a battery supercapacitor hybrid device was fabricated, comprising Cu-PYDC-MOF and activated carbon (AC) electrodes. The device showcased energy and power density of 17 W h kg -1 and 2550 W kg -1, respectively. Dunn's model was employed to gain deeper insights into the capacitive and diffusive contributions of the device. With their performance and versatility, the PYDC-based MOFs stand at the forefront of energy technology, ready to power a brighter future for upcoming generations.

Role of genetic polymorphisms in clopidogrel response variability: a systematic review.

INTRODUCTION: Clopidogrel is a P2Y12 inhibitor that has become a mainstay treatment following percutaneous intervention with drug-eluting stent placement to decrease restenosis and its potential complications, including sudden cardiac death and ischaemic strokes in patients with significant vascular disease. AREAS COVERED: As a prodrug, the metabolism and efficacy of clopidogrel are contingent on the presence of wild-type CYP450 (CYP2C19) alleles. Genetic polymorphisms and variants are well known to impair its ability to prevent major adverse cardiovascular events in these patients, with inadequate response rates as high as 30% in previous publications. Patterns of allelic frequencies are expected to exhibit similarities between individuals of the same ancestry, ethnic group or geographic region. Accordingly, we seek to further elucidate worldwide prevalence rates for genetic polymorphisms in the CYP2C19-dependent metabolism of clopidogrel and review the potential of personalised CYP2C19 genotyping in clinical practice to mitigate this high treatment resistance and its associated burden on patients. EXPERTS' COMMENTARY: Our findings support the consideration of genotyping before initiation of therapy to guide adequate dosage or substitutions of other P2Y12 inhibitors to promote personalised, precision medicine and to prevent adverse events when these therapies may inevitably fail in patients with variants of the CYP450 (CYP2C19) system.

Redox active pyridine-3,5-di-carboxylate- and 1,2,3,4-cyclopentane tetra-carboxylate-based cobalt metal-organic frameworks for hybrid supercapacitors.

In the pursuit of developing superior energy storage devices, an integrated approach has been advocated to harness the desirable features of both batteries and supercapacitors, particularly their high energy density, and high-power density. Consequently, the emergence of hybrid supercapacitors has become a subject of increasing interest, as they offer the potential to merge the complementary attributes of these two technologies into a single device, thereby surpassing the limitations of conventional energy storage systems. In this context the Metal-Organic Frameworks (MOFs), consisting of metal centers and organic linkers, have emerged as highly trending materials for energy storage by virtue of their high porosity. Here, we investigate the electrochemical performance of cobalt-pyridine-3,5-di-carboxylate-MOF (Co-PDC-MOF) and cobalt-1,2,3,4-cyclopentane tetra-carboxylate-MOF (Co-CPTC-MOF). In the setup involving the analysis of Co-PDC-MOF and Co-CPTC-MOF materials, a configuration comprising three electrodes was utilized. Drawing upon the promising initial properties of CPTC, a battery device was fabricated, comprising Co-CPTC-MOF, and activated carbon (AC) electrodes. Retaining a reversible capacity of 97% the device showcased impressive energy and power density of 20.7 W h g-1 and 2608.5 W kg-1, respectively. Dunn's model was employed, to gain deeper insights into the capacitive and diffusive contributions of the device.

Subacute Stent Thrombosis in a Patient With COVID-19 Despite Adherence to Antiplatelets.

The coronavirus disease 2019 (COVID-19) creates a significant burden on the cardiovascular system. Moreover, diagnosing coronary artery disease in patients with COVID-19 may be clinically challenging. Herein, we present a case of in-hospital stent thrombosis and thrombotic occlusion of the right coronary artery after initial revascularization and adherence to antiplatelet therapy.